Skip to main navigation Skip to search Skip to main content

Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with crohn's disease: A post Hoc analysis of the PAILOT randomized controlled trial

  • Manar Matar
  • , Raanan Shamir
  • , Dan Turner
  • , Efrat Broide
  • , Batia Weiss
  • , Oren Ledder
  • , Anat Guz-Mark
  • , Firas Rinawi
  • , Shlomi Cohen
  • , Chani Topf-Olivestone
  • , Ron Shaoul
  • , Baruch Yerushalmi
  • , Shomron Ben-Horin
  • , Amit Assa

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with crohn's disease: A post Hoc analysis of the PAILOT randomized controlled trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science